Christopher Simon

CIK: 0001674993

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SHC

Sotera Health Co

Director

HAE

HAEMONETICS CORP

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SHC
Sotera Health Co
May 22, 2026
Award(A)
Direct
15K shares-
HAE
HAEMONETICS CORP
May 15, 2026
Award(A)
Direct
78.3K shares-
HAE
HAEMONETICS CORP
May 15, 2026
Tax Payment(F)
Direct
9.7K shares at avg. $56.29$545K
HAE
HAEMONETICS CORP
May 30, 2025
Award(A)
Direct
66.7K shares-
HAE
HAEMONETICS CORP
May 30, 2025
Tax Payment(F)
Direct
26.2K shares at avg. $69.38$1.8M
SHC
Sotera Health Co
May 22, 2025
Award(A)
Direct
19.1K shares-
HAE
HAEMONETICS CORP
May 16, 2025
Award(A)
Direct
21.4K shares-
HAE
HAEMONETICS CORP
May 16, 2025
Tax Payment(F)
Direct
7.1K shares at avg. $70.31$498K
HAE
HAEMONETICS CORP
May 15, 2025
Tax Payment(F)
Direct
2.4K shares at avg. $69.38$166K
HAE
HAEMONETICS CORP
Aug 29, 2024
Other(J)
Direct
39.7K shares at avg. $75.56$3.0M

		Type	Shares	Price		Ownership
May 22, 2026	SHC Sotera Health Co	Award(A)	14,970	-	$0	Direct
May 15, 2026	HAE HAEMONETICS CORP	Award(A)	78,344	-	$0	Direct
May 15, 2026	HAE HAEMONETICS CORP	Tax Payment(F)	9,681	$56.29	$544,943	Direct
May 30, 2025	HAE HAEMONETICS CORP	Award(A)	66,666	-	-	Direct
May 30, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	26,234	$69.38	$1,820,115	Direct
May 22, 2025	SHC Sotera Health Co	Award(A)	19,132	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Award(A)	21,405	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	7,089	$70.31	$498,428	Direct
May 15, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	2,391	$69.38	$165,888	Direct
Aug 29, 2024	HAE HAEMONETICS CORP	Other(J)	39,704	$75.56	$3,000,034	Direct

1-10 of 10 transactions

About Simon, Christopher

Simon, Christopher (SEC CIK 0001674993) files insider reports with the SEC as Director of Sotera Health Co (SHC) and President & CEO of HAEMONETICS CORP (HAE).

Signal8 holds 7 ownership filings by Simon, Christopher, all Form 4s, filed between Sep 3, 2024 and May 27, 2026. Those filings report 10 transactions, from Aug 29, 2024 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Simon, Christopher's filings is in BOSTON, MA.

Recent filings by Simon, Christopher

May 22, 2026: Grant or award of SHC shares (Form 4, code A).
May 15, 2026: Grant or award of HAE shares (Form 4, code A).
May 15, 2026: Tax withholding of HAE shares (Form 4, code F).
May 30, 2025: Grant or award of HAE shares (Form 4, code A).
May 30, 2025: Tax withholding of HAE shares (Form 4, code F).

Other insiders filing for Sotera Health Co (SHC)

Petras Michael B. Jr., Executive Chairman
Rutz Michael P, President of Sterigenics
Lyons Jonathan M., Sr. Vice President, CFO
Klee Ann R., Director
SHADER ALTON, Chief Executive Officer
Kyle Richard G, Director

How to read Form 4 transaction codes